< Back to companies

Developer of AI-based diagnostic assistant intended to provide an accurate sepsis score from a drop of blood. The company's technology is mainly used for neonatal sepsis diagnosis and avoids unnecessary antibiotic treatment, enabling doctors with accurate, and cost-effective alternatives to existing diagnostic methods.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2022
Website
www.neosens-dx.com/

Categories

AI / MLDiagnosticsInfectious DiseasePediatric Care
Only accessible to MedStartr community members. Join now

What do you think of Neosens?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now